{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:44:00Z","timestamp":1793040240250,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004162","name":"Meath Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.psyneuen.2018.05.019","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T05:20:23Z","timestamp":1526707223000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes"],"prefix":"10.1016","volume":"95","author":[{"given":"Kelly","family":"Doolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Allers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Pleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Liesener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"O\u2019Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Frodl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Harkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"O\u2019Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.psyneuen.2018.05.019_bib0005","doi-asserted-by":"crossref","first-page":"e112945","DOI":"10.1371\/journal.pone.0112945","article-title":"Involvement of the kynurenine pathway in human glioma pathophysiology","volume":"9","author":"Adams","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","article-title":"Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: comparison of multiple ketamine infusions and electroconvulsive therapy","volume":"100","author":"Allen","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0015","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1046\/j.1471-4159.1995.64062607.x","article-title":"The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure","volume":"64","author":"Basile","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0145-2134(02)00541-0","article-title":"Development and validation of a brief screening version of the childhood trauma questionnaire","volume":"27","author":"Bernstein","year":"2003","journal-title":"Child. Abuse Negl."},{"issue":"Pt B","key":"10.1016\/j.psyneuen.2018.05.019_bib0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","article-title":"Kynurenine pathway metabolites and suicidality","volume":"112","author":"Bryleva","year":"2017","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jad.2010.03.004","article-title":"Subregional hippocampal deformations in major depressive disorder","volume":"126","author":"Cole","year":"2010","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0327(89)90051-7","article-title":"Decreased plasma tryptophan levels in major depression","volume":"16","author":"Cowen","year":"1989","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102226","article-title":"Diurnal hypothalamic-pituitary-adrenal axis measures and inflammatory marker correlates in Major depressive disorder","volume":"18","author":"Doolin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psych."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cne.903210313","article-title":"Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus","volume":"321","author":"Du","year":"1992","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1999.tb07618.x","article-title":"Stress, corticotropin-releasing hormone, glucocorticoids, and the immune\/inflammatory response: acute and chronic effects","volume":"876","author":"Elenkov","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0060","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00726-013-1602-1","article-title":"Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease","volume":"45","author":"Fatokun","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0065","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"Free surfer","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0075","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1002\/hbm.22584","article-title":"BDNF Val66Met genotype interacts with childhood adversity and influences the formation of hippocampal subfields","volume":"35","author":"Frodl","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0080","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1038\/tp.2012.14","article-title":"Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder","volume":"2","author":"Frodl","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"59","key":"10.1016\/j.psyneuen.2018.05.019_bib0085","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1176\/appi.ajp.159.7.1112","article-title":"Hippocampal changes in patients with a first episode of major depression","volume":"1","author":"Frodl","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0090","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S","article-title":"Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism","volume":"31","author":"Fujigaki","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0447.2010.01646.x","article-title":"Medical comorbidity in recurrent versus first-episode depressive patients","volume":"123","author":"Gili","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/(SICI)1097-4547(19971101)50:3<457::AID-JNR12>3.0.CO;2-3","article-title":"Characterization of rat brain kynurenine aminotransferases I and II","volume":"50","author":"Guidetti","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00018-009-0166-4","article-title":"Structure, expression and function of kynurenine aminotransferases in human and rodent brains","volume":"67","author":"Han","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biopsych.2013.01.005","article-title":"Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study","volume":"74","author":"Huang","year":"2013","journal-title":"Biol. Psych."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbi.2012.05.010","article-title":"Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation","volume":"26","author":"Hughes","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","article-title":"A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI","volume":"115","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1746.2003.03259.x","article-title":"Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma","volume":"19","author":"Ishio","year":"2004","journal-title":"J. Gastroenterol. Hepatol"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/srep00667","article-title":"Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile","volume":"2","author":"Kaddurah-Daouk","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0300-9475.2004.01378.x","article-title":"Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells","volume":"59","author":"Kai","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0145","first-page":"664","article-title":"Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression","volume":"10","author":"Koo","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.09.017","article-title":"A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers","volume":"48","author":"Lopresti","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psych."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2011.09.029","article-title":"Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway","volume":"196","author":"Maes","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/10253890701754068","article-title":"A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression","volume":"11","author":"Miura","year":"2008","journal-title":"Stress"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00702-011-0741-3","article-title":"The role of the kynurenine metabolism in major depression","volume":"119","author":"Myint","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0180","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2015.12.004","article-title":"Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders","volume":"112","author":"O\u2019Farrell","year":"2017","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-8993(91)91583-M","article-title":"Two kynurenine aminotransferases in human brain","volume":"542","author":"Okuno","year":"1991","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.psyneuen.2018.05.019_bib0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2164-7-115","article-title":"Cell-type specific gene expression profiles of leukocytes in human peripheral blood","volume":"16","author":"Palmer","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0200","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00726-014-1766-3","article-title":"Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1","volume":"46","author":"Pantouris","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psych."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","article-title":"Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies","volume":"68","author":"R\u00e9us","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.comppsych.2010.04.011","article-title":"Clinical differences between first and recurrent episodes in depressive patients","volume":"52","author":"Roca","year":"2011","journal-title":"Compr. Psych."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12021-015-9266-5","article-title":"Estimating intracranial volume in brain research: an evaluation of methods","volume":"13","author":"Sargolzaei","year":"2015","journal-title":"Neuroinformatics"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0225","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","article-title":"Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder","volume":"52","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"Pt B","key":"10.1016\/j.psyneuen.2018.05.019_bib0240","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","article-title":"Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients","volume":"13","author":"Schwieler","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0250","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2119\/molmed.2011.00201","article-title":"Natural killer (NK) cells in antibacterial innate immunity: angels or devils?","volume":"18","author":"Souza-Fonseca-Guimaraes","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0260","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0265","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J. Affect Disord."},{"issue":"2","key":"10.1016\/j.psyneuen.2018.05.019_bib0270","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions. Nature reviews","volume":"1","author":"V\u00e9csei","year":"2013","journal-title":"Drug Discov."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0275","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fnagi.2014.00264","article-title":"The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer\u2019s disease","volume":"6","author":"Voevodskaya","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0280","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1002\/cne.24024","article-title":"Noncanonical connections between the subiculum and hippocampal CA1","volume":"524","author":"Xu","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.psyneuen.2018.05.019_bib0285","first-page":"716859","article-title":"The involvement of neuroinflammation and kynurenine pathway in Parkinson\u2019s disease","author":"Zinger","year":"2011","journal-title":"Parkinson\u2019s Dis."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018303561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018303561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:59:29Z","timestamp":1759683569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453018303561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":57,"alternative-id":["S0306453018303561"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.05.019","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}